NYSE:AMPE

Ampio Pharmaceuticals Stock Insider Trading

etoro logo Buy AMPE
*Your capital is at risk
$0.183
+0 (+0%)
At Close: Jun 03, 2026

Ampio Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 9.13M and sold 661.13K AMPE shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
0
Buy 9.13M shares
Sell 661.13K shares
78% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Jun 09, 2023
Buy
Common Stock
P-Purchase
Buchi J Kevin
Director
Director 21 858
Value: $6K
Jun 09, 2023
Buy
Common Stock
P-Purchase
Buchi J Kevin
Director
Director 21 858
Value: $6K
Jun 08, 2023
Buy
Common Stock
P-Purchase
Buchi J Kevin
Director
Director 25 000
Value: $7K
Jun 08, 2023
Buy
Common Stock
P-Purchase
Buchi J Kevin
Director
Director 25 000
Value: $7K
May 24, 2023
Buy
Common Stock
P-Purchase
Martino Michael A
CEO
CEO / President 76 890
Value: $22.1K
May 24, 2023
Buy
Common Stock
P-Purchase
Martino Michael A
CEO
CEO / President 76 890
Value: $22.1K
May 16, 2023
Buy
Common Stock
P-Purchase
Buchi J Kevin
Director
Director 32 534
Value: $9K
May 16, 2023
Buy
Common Stock
P-Purchase
Buchi J Kevin
Director
Director 32 534
Value: $9K
May 15, 2023
Buy
Common Stock
P-Purchase
Buchi J Kevin
Director
Director 44 026
Value: $10.9K
May 15, 2023
Buy
Common Stock
P-Purchase
Buchi J Kevin
Director
Director 44 026
Value: $10.9K
May 12, 2023
Buy
Common Stock
P-Purchase
Buchi J Kevin
Director
Director 23 440
Value: $6K
May 12, 2023
Buy
Common Stock
P-Purchase
Buchi J Kevin
Director
Director 23 440
Value: $6K
May 12, 2023
Buy
Common Stock
P-Purchase
Stevens David R
Director
Director 45 000
Value: $10K
May 12, 2023
Buy
Common Stock
P-Purchase
Stevens David R
Director
Director 45 000
Value: $10K
May 11, 2023
Buy
Common Stock
P-Purchase
Stevens David R
Director
Director 25 000
Value: $5K
May 11, 2023
Buy
Common Stock
P-Purchase
Stevens David R
Director
Director 25 000
Value: $6K
May 11, 2023
Buy
Common Stock
P-Purchase
Stevens David R
Director
Director 25 000
Value: $6K
May 11, 2023
Buy
Common Stock
P-Purchase
Stevens David R
Director
Director 25 000
Value: $5K
Mar 01, 2022
Buy
Stock Option (Right to Buy)
A-Award
Jobes Elizabeth Varki
Director
Director 150 000
Value: $67.7K
Mar 01, 2022
Buy
Stock Option (Right to Buy)
A-Award
Jobes Elizabeth Varki
Director
Director 150 000
Value: $67.7K
Feb 09, 2022
Buy
Stock Option (right to buy)
A-Award
Bar-or David
Director
Director 75 000
Value: $39.7K
Feb 09, 2022
Buy
Stock Option (right to buy)
A-Award
Bar-or David
Director
Director 75 000
Value: $39.7K
Feb 08, 2022
Buy
Common Stock
J-Other
Jobes Elizabeth Varki
Insider
Other 0
Value: $0
Feb 08, 2022
Buy
Common Stock
J-Other
Jobes Elizabeth Varki
Insider
Other 0
Value: $0
Jan 01, 2022
Sell
Common Stock
F-InKind
Stokely Dan
CFO
C-Suite Officer 22 914
Value: $13.1K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT AMPIO PHARMACEUTICALS INC
Ampio Pharmaceuticals
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an intravenous ampion treatment that is in Phase II clinical trial to treat adult COVID-19 patients requi...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE